Lobbying by Stem Cell Network: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
Innovation, Science and Economic Development Canada (ISED)2
Privy Council Office (PCO)1
Prime Minister's Office (PMO)1
Finance Canada (FIN)1
Federal Economic Development Agency for Southern Ontario (FedDev)1
Registrations in effect
In-house (organization)In effect since Sep 4, 2026Receives government funding
Filed by Cate Murray, President & Chief Executive Officer
Lobbyists
Cate Murray · President & Chief Executive OfficerFormer public office holder
Formerly Senior Policy Advisor, Communications & Policy Branches, Canadian Institutes of Health Research (2002–2010)
Formerly Special Assistant, Minister's Office, Environment Canada (2000–2002)
Institutions they may lobby: Federal Economic Development Agency for Southern Ontario (FedDev), Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Privy Council Office (PCO), Senate of Canada
What they're lobbying on (3)Hide details
Communicating with federal officials regarding the Strategic Science Fund and its role in supporting Canada’s research and innovation ecosystem, to ensure sustained support for stem cell and regenerative medicine research. Engagement will focus on enhancing stable funding to advance scientific excellence, collaboration, and sector growth.
Communicating with federal officials on the modernization of regulatory frameworks governing stem cell research and regenerative medicine products.
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Kaili Levesque · Associate Deputy Minister, Federal Economic Development Agency for Southern Ontario (FedDev)
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Communicating with federal officials regarding the Strategic Science Fund and its role in supporting Canada’s research and innovation ecosystem, to ensure sustained support for stem cell and regenerative medicine research. Engagement will focus on enhancing stable funding to advance scientific excellence, collaboration, and sector growth.Read more
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Justine Frame · Policy Advisor to the Minister of Health, House of Commons
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Communicating with federal officials regarding the Strategic Science Fund and its role in supporting Canada’s research and innovation ecosystem, to ensure sustained support for stem cell and regenerative medicine research. Engagement will focus on enhancing stable funding to advance scientific excellence, collaboration, and sector growth.Read more
David McFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
Communicating with federal officials regarding the Strategic Science Fund and its role in supporting Canada’s research and innovation ecosystem, to ensure sustained support for stem cell and regenerative medicine research. Engagement will focus on enhancing stable funding to advance scientific excellence, collaboration, and sector growth.Read more
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
Nipun Vats · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Continued support for life sciences funding and the emerging area of stem
cell and regenerative medicine research. Lobbying is about building
awareness about the field and the strength of talent that works within the
field.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.